🔎 Trials Near Me

Akèy › Maladi Crohn › Massachusetts › New Bedford

Etid klinik pou Maladi Crohn nan New Bedford, MA

6 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote New Bedford (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Lucida Clinical Trials /ID# 282000, New Bedford
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4
  • Lucida Clinical Trials LLC, New Bedford
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Ap rekriteFaz 2
  • Lucida Clinical Trials /ID# 266548, New Bedford
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Lucida Clinical Trials, New Bedford
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07499232

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Lucida Clinical Trials, New Bedford
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • Lucida Clinical Trials, LLC, New Bedford
Laj 18 a 75 · Tout sèks · Mizajou Apr 27, 2026 · NCT06456593

Etid Maladi Crohn nan lòt vil

Lòt etid nan New Bedford

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.